Malika Ammam received her MS degree from the University of Pierre et Marie CURIE in July 2002 and her PhD from the University of Paris Sud XI, France in September 2005. From 2006 to 2007, she worked as a research fellow at the University of Kansas in collaboration with Pinnacle Technology Inc. (USA). From 2007 to 2010, she was a research associate at KU Leuven, Belgium. From 2010 to 2012, she worked at the University of Ontario Institute of Technology in collaboration with Alcohol Countermeasure Systems Corporation, Canada. She has also held the prestigious Rosalind Franklin fellowship.
A recent study compared the start of renal replacement therapy (RRT) in African-American (AA) children with chronic kidney disease (CKD) to non-AA children, and found that African-American kids have ... Read more
Diabetes is the leading cause of chronic kidney disease (CKD) and eventual kidney failure. A collaborative new study between several Spanish institutions proposes a new approach to slow the ... Read more
A recent study evaluated the prevalence of bacteremia — the presence of bacteria in blood — in patients with chronic kidney diseases (CKD) and renal transplants, discovering that resistance in ... Read more
A recent analysis of the CORAL trial data suggests that patients with chronic kidney disease (CKD) who successfully responded to renal artery stenting (RAS), a procedure to open narrowed and ... Read more
Elevated doses of atorvastatin, a member of a drug class known as statins, does not reduce the risk of acute kidney injury after cardiac surgery, according to a recent study titled “High-Dose ... Read more
In a recent paper published in PLoS One journal entitled “Molecular Markers of Tubulointerstitial Fibrosis and Tubular Cell Damage in Patients with Chronic Kidney Disease“, researchers reported novel insights on ... Read more